MEDTRMeditera Tıbbi Malzeme

CompanyPeriod 2026-Q115 periods of history
Financial Summary2026-Q1
Revenue646 mn
Gross Profit214 mn
Operating Profit10.1 mn
Net Profit for the Period-53.4 mn
Total Assets3.8 bn
Shareholders' Equity3.2 bn
Current Assets1.9 bn
Short-term Liabilities531 mn
Financial Ratios2026-Q1
Current Ratio3.58
Quick Ratio2.49
Debt / Equity0.20
Gross Margin33.14%
Operating Margin1.56%
Net Margin-8.26%
Return on Equity (ROE)-1.68%
Return on Assets (ROA)-1.40%
Members Only
Financial Ratios
Membership is required to view this detail.
Upgrade membership
Year-over-Year2026-Q1 → 2025-Q1
Revenue-17.7%
Net Profit+43.2%
Gross Profit-13.1%
Gross Margin (pts)+1.8%
Net Margin (pts)+3.7%
Operating Margin (pts)-1.9%
Last 8 Periods
Revenue · quarterly646 mn
2024-Q2: 536 mn24-Q22024-Q3: 823 mn24-Q32024-Q4: 781 mn24-Q42025-Q1: 786 mn25-Q12025-Q2: 470 mn25-Q22025-Q3: 742 mn25-Q32025-Q4: 1.2 bn25-Q42026-Q1: 646 mn26-Q1
Net Profit · quarterly-53.4 mn
2024-Q2: 36.8 mn24-Q22024-Q3: 28.2 mn24-Q32024-Q4: 12.4 mn24-Q42025-Q1: -93.9 mn25-Q12025-Q2: -3.5 mn25-Q22025-Q3: 17.7 mn25-Q32025-Q4: 66.8 mn25-Q42026-Q1: -53.4 mn26-Q1
Gross Profit · quarterly214 mn
2024-Q2: 226 mn24-Q22024-Q3: 324 mn24-Q32024-Q4: 280 mn24-Q42025-Q1: 247 mn25-Q12025-Q2: 157 mn25-Q22025-Q3: 228 mn25-Q32025-Q4: 332 mn25-Q42026-Q1: 214 mn26-Q1
Funds Holding This Stock4 funds
FundNamePortfolio Weight
RPMROTA PORTFÖY İLAÇ VE MEDİKAL TEKNOLOJİLERİ DEĞİŞKEN FON4.26%
ELZASTRA PORTFÖY KATILIM HİSSE SENEDİ FONU (HİSSE SENEDİ YOĞUN FON)1.80%
GOHGARANTİ PORTFÖY BIST 100 DIŞI ŞİRKETLER HİSSE SENEDİ (TL) FONU (HİSSE SENEDİ YOĞUN FON)1.45%
GZGGARANTİ PORTFÖY SAĞLIK VE GENETİK TEKNOLOJİLERİ DEĞİŞKEN FON0.97%
Members Only
Fund Positions
Membership is required to view this detail.
Upgrade membership
Company Profile
Tıbbi malzeme üretimi
Legal nameMeditera Tıbbi Malzeme
Sector—
FoundedFaal Alanı
Phone(0232)5135110
AddressİBNİ MELEK OSB MAHALLESİ TOSBİ YOL 4 SOKAK NO:29 TİRE-İZMİR